SCHEMBL30954136

SCHEMBL30954136

COc1cc2c(cc1C)N(C)CCO2

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.56
LMNA P02545 1/20 0.49
THRB P10828 1/20 0.49
L3MBTL1 Q9Y468 4/20 0.47
KMT2A Q03164 2/20 0.47
PDE10A Q9Y233 1/20 0.46
POLB P06746 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 1/20 0.43
FGB P02675 1/20 0.43
PKM P14618 2/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
TP53 P04637 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27434483 1.00 RXFP1 (0.56) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL27432567 0.83 L3MBTL1 (0.50) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL27432476 0.83 RXFP1 (0.46) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL30954097 0.83 POLB (0.47) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL27433242 0.83 POLB (0.47) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL1494287 0.80 RXFP1 (0.45) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL31017016 0.79 RXFP1 (0.46) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL16404599 0.78 L3MBTL1 (0.47) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL20183068 0.78 RXFP1 (0.43) RXFP1LMNATHRBL3MBTL1KMT2A
SCHEMBL1494271 0.78 RXFP1 (0.46) RXFP1LMNATHRBL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed